Sitagliptin Vildagliptin And Saxagliptin Dipeptidyl Peptidase

PDF
DOC
PPT
Sitagliptin (JANUVIA®) - RxFiles | Drug Index

Sitagliptin (JANUVIA®) - RxFiles | Drug Index

RxFiles: Q&A Summary www.RxFiles.ca - Nov, 2008 Rene Breault BScPharm, PharmD Candidate; L. Regier BSP BA, B. Jensen BSP Sitagliptin (JANUVIA®)
Mon, 28 Jul 2014 01:26:00 GMT
Advice from the Scottish Medicines Consortium relevant to ...

Advice from the Scottish Medicines Consortium relevant to ...

Advice from the Scottish Medicines Consortium relevant to SIGN 116 – Management of Diabetes (correct at 26 April 2011) 1 Drug Manufacturer Date
Sun, 27 Jul 2014 19:36:00 GMT
New Drugs in Development for the Treatment of Diabetes

New Drugs in Development for the Treatment of Diabetes

92 Diabetes Spectrum Volume 22, Number 2, 2009 In Brief A variety of new agents are in development for the treatment of type 1 or type 2 diabetes.
Tue, 29 Jul 2014 05:36:00 GMT
Open Access Full Text Article review Alogliptin: a new ...

Open Access Full Text Article review Alogliptin: a new ...

© 2009 Andukuri et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the ...
Tue, 29 Jul 2014 19:47:00 GMT
A New Therapy of Type 2 Diabetes: DPP-4 Inhibitors

A New Therapy of Type 2 Diabetes: DPP-4 Inhibitors

1 A New Therapy of Type 2 Diabetes: DPP-4 Inhibitors Tatjana Ábel National Health Center Hungary 1. Introduction Type 2 diabetes is a progressive disease which is ...
Tue, 29 Jul 2014 13:35:00 GMT
Comparison of efficacy between incretin-based therapies ...

Comparison of efficacy between incretin-based therapies ...

comparative trials analyzing efficacy, tolerability and safety profiles between the agents from these two classes. Physiology of incretins The classic ‘incretin ...
Wed, 30 Jul 2014 06:25:00 GMT
Launch Excellence in the Diabetes Market - IMS Health

Launch Excellence in the Diabetes Market - IMS Health

IMS HEALTH |LAUNCH EXCELLENCE IN THE DIABETES MARKET 5 WHITE PAPER |DIABETES LAUNCH EXCELLENCE The competitive success of ...
Tue, 29 Jul 2014 05:07:00 GMT
201280Orig1s000 - Food and Drug Administration

201280Orig1s000 - Food and Drug Administration

center for drug evaluation and research application number: 201280orig1s000 cross discipline team leader review
Mon, 28 Jul 2014 00:22:00 GMT
Pancreatic Safety of Incretin-Based Drugs — FDA and EMA ...

Pancreatic Safety of Incretin-Based Drugs — FDA and EMA ...

n engl j med 370;9 nejm.org27, 2014february PERSPECTIVE 795 Pancreatic Safety of Incretin-Based Drugs efficacy in improving glycemic control. The benefit ...
Sun, 20 Jul 2014 02:12:00 GMT
National Medicines VOLUME 17 Information Centre 2011

National Medicines VOLUME 17 Information Centre 2011

References for type 2 Diabetes Mellitus Vol 17 No 6 2011 1. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of
Mon, 28 Jul 2014 21:00:00 GMT